Skip to content
AnalystLens

AGILENT TECHNOLOGIES, INC. Annual Report, Year Ended Oct 31, 2004

Filing Date
Filed December 21, 2004
Period End
October 31, 2004
Security
A
In the record · 2016–202610-K1010-Q338-K115

A filed 10 annual reports (10-K), 33 quarterly reports (10-Q) and 115 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Jul ’17Jul ’17
  2. Material agreement8-K · Oct ’19Oct ’19
  3. Leadership change8-K · Dec ’21Dec ’21
  4. Leadership change8-K · Oct ’25Oct ’25

Summary

Summary of the 10-K filed December 21, 2004. Cited figures are marked; the original filing is the authoritative source.

Agilent Technologies, Inc. reported solid financial performance for the fiscal year ended October 31, 2004, marking a significant recovery from the prior two years.

Net revenue increased by 19% to $7.18 billiona, driven by growth across all four business segments, particularly Test and Measurement and Life Sciences and Chemical Analysis. The company successfully reduced operating expenses as a percentage of revenue, benefiting from ongoing restructuring efforts and cost controls, which resulted in a return to profitability with income from continuing operations of $349 million. Agilent maintained a strong liquidity position, ending the year with $2.3 billion in cash and cash equivalents, and focused on investing in new product development and strategic opportunities.

The company experienced a notable slowdown in its Semiconductor Products and Automated Test businesses in the latter half of the year due to customer inventory build-up, but overall performance demonstrated resilience and strategic repositioning. Agilent continued its global expansion, with international revenue accounting for 69%b of total net revenue. Key strategic initiatives included streamlining IT systems and managing its cost structure through outsourcing and operational efficiencies, positioning the company for sustained growth.

Investors should note the company's significant restructuring charges incurred over the past few years, which are impacting current operations but are intended to drive future efficiency. While the company has returned to profitability, the market conditions in its semiconductor-related businesses remain a key factor to monitor. Agilent's focus on innovation in its Life Sciences and Chemical Analysis segments, alongside improvements in its core Test and Measurement offerings, suggests a diversified approach to market challenges.

Key Highlights

  1. Net revenue increased 19% year-over-year to $7.18 billion, driven by broad-based growth across all four business segments.
  2. Returned to profitability with income from continuing operations of $349 million, a significant improvement from prior years' losses.
  3. Operating expenses as a percentage of revenue decreased substantially from 62% in FY2003 to 38% in FY2004 due to cost controls and restructuring savings.
  4. Ended the fiscal year with a strong cash position of $2.3 billion, indicating solid financial health and liquidity.
  5. International revenue represented a substantial 69% of total net revenue, highlighting Agilent's global market presence.
  6. Continued to invest in research and development, introducing new products in Life Sciences & Chemical Analysis and Automated Test segments, while navigating a slowdown in semiconductor markets in the latter half of the year.

Frequently Asked Questions

  1. What was Agilent's overall financial performance in fiscal year 2004?

    Agilent Technologies demonstrated a strong recovery in fiscal year 2004, reporting a 19% increase in net revenue to $7.18 billion and a return to profitability with $349 million in income from continuing operations. This improvement was driven by revenue growth across all segments and significant reductions in operating expenses, largely due to ongoing restructuring and cost-saving initiatives.

  2. Which business segments performed best, and were there any areas of concern?

    The Test and Measurement and Life Sciences and Chemical Analysis segments showed solid growth. However, the Semiconductor Products and Automated Test segments experienced a slowdown in the second half of the year due to excess inventory at customer sites, particularly in the wireless handset manufacturing test markets. Despite this, the company's overall diversified approach helped mitigate the impact.

  3. What is the company's strategy for managing costs and improving efficiency?

    Agilent has been actively implementing restructuring plans to reduce its cost structure, which included workforce reductions and facility consolidations. They are also focusing on a more variable cost structure by utilizing contract manufacturers and third-party service providers. The completion of ERP and CRM projects is expected to yield further cost savings and operational improvements.

  4. How is Agilent positioned regarding liquidity and future investments?

    Agilent ended fiscal year 2004 with a strong liquidity position, holding $2.3 billion in cash and cash equivalents. The company is making strategic investments in information technology and facilities infrastructure, and continues to invest in research and development to support new product introductions and maintain its competitive edge.